Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines
- by Lysander Beaumont
- Dec, 31 2025
Patent litigation in generic drug markets is delaying affordable medicines by years. Learn how Orange Book listings, serial lawsuits, and pay-for-delay settlements are shaping access to low-cost drugs-and what’s being done to stop it.
Read More
